|
FKRP expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.67376999999913E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.76689999987457E-07 |
| Normal-vs-Stage2 |
1.443920E-03 |
| Normal-vs-Stage3 |
6.197900E-02 |
| Normal-vs-Stage4 |
3.5177999999636E-06 |
| Stage1-vs-Stage2 |
9.751400E-01 |
| Stage1-vs-Stage3 |
1.911040E-01 |
| Stage1-vs-Stage4 |
1.837170E-01 |
| Stage2-vs-Stage3 |
3.003600E-01 |
| Stage2-vs-Stage4 |
2.260600E-01 |
| Stage3-vs-Stage4 |
1.907620E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.394610E-04 |
| Normal-vs-AfricanAmerican |
5.22939999969552E-07 |
| Normal-vs-Asian |
4.117400E-01 |
| Caucasian-vs-AfricanAmerican |
2.877500E-02 |
| Caucasian-vs-Asian |
3.966200E-01 |
| AfricanAmerican-vs-Asian |
8.995800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.99199999617994E-08 |
| Normal-vs-Female |
3.379900E-02 |
| Male-vs-Female |
1.203820E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.585400E-04 |
| Normal-vs-Extreme_Weight |
4.72279999996772E-07 |
| Normal-vs-Obese |
2.724900E-03 |
| Normal-vs-Extreme_Obese |
2.725600E-02 |
| Normal_Weight-vs-Extreme_Weight |
4.961200E-01 |
| Normal_Weight-vs-Obese |
6.204200E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.367000E-01 |
| Extreme_Weight-vs-Obese |
2.197600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.263400E-01 |
| Obese-vs-Extreme_Obese |
9.157600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.930800E-01 |
| Normal-vs-Age(41-60Yrs) |
1.035960E-04 |
| Normal-vs-Age(61-80Yrs) |
7.17150000051348E-07 |
| Normal-vs-Age(81-100Yrs) |
1.53570000049896E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.606200E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.674000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.695000E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.309600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.804320E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.016700E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.5877000000073E-05 |
| Normal-VS-Type2 PRCC |
3.97669999996353E-06 |
| Normal-VS-KIRP CIMP |
8.874400E-01 |
| Normal-VS-Unclassified PRCC |
7.001500E-04 |
| Type1 PRCC-VS-Type2 PRCC |
2.809500E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.795750E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.487600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.515800E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
3.512600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.445020E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.55306999999327E-05 |
| Normal-vs-N1 |
4.094600E-01 |
| Normal-vs-N2 |
1.549820E-02 |
| N0-vs-N1 |
2.651800E-02 |
| N0-vs-N2 |
4.388800E-01 |
| N1-vs-N2 |
1.469760E-01 |
|
|
